Skip to main content
OHI logo

OHI

Omega Healthcare Investors Inc
$48.30 -0.53 (-1.09%) At close · Jul 10
Market Cap
$14.38B
Shares
297,802,000

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$48.30 Open$48.96 Day$47.83–48.97 52W$34.03–50.10 Avg vol 30d2.2M Short int14.1M · 4.7% float · 5.8d Short vol47% Last earningsApr 28, 2026 DataJan 2020–Jul 2026 Filing10-Q · Apr 29
Up next
Next earnings call
Jul 28, 2026 Est · unconfirmed · in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Apr 29, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Equibles Rating blended score · not investment advice
      Overall
      Strong Buy
      SellHoldBuy
      Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very Low
      Market backdrop VIX 15 · calm Equity put/call 0.55
      Technical
      price trend
      Strong Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +7%
      above
      Price vs 50-day avg +3%
      above
      RSI (14) 56
      neutral
      MACD trend Positive
      52-week position 89%
      near high
      Momentum
      relative strength
      Very Strong
      1-month return +5%
      trailing
      6-month return +10%
      trailing
      YTD return +11%
      this year
      Relative strength +1%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $47 › 200d $45 — 50d above 200d
      Institutional flow Accumulating
      41 of 745 funds reported for Jun 30 · net +51.1K sh shares · +7 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      4.73% of float · ▲ +1.9% MoM · 5.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      745 holders — near 3-yr high, broad support
      Squeeze score 58
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +13%
      Y/Y
      EPS growth +25%
      Y/Y
      Valuation P/E 23.2
      below peers
      Buyback $500.0M
      authorized
      Balance sheet $4.2B
      net debt
      Quant / Vol
      risk profile
      Very Low
      Volatility 20%
      annualized · 1-yr
      Max drawdown −11%
      past year
      ATR 2.0%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record
      Latest guidance · from the 8-K filed Apr 28, 2026
      Adjusted FFO · full year 2026 Non-GAAP Raised $3.22

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Buy
      0 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +7% Bullish
      Price vs 50-day avg
      +3% Bullish
      RSI (14)
      56 Neutral
      MACD trend
      Positive Bullish
      52-week position
      89% Bullish
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $47 › 200d $45 — 50d above 200d
      Institutional flow Accumulating
      41 of 745 funds reported for Jun 30 · net +51.1K sh shares · +7 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      4.73% of float · ▲ +1.9% MoM · 5.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      745 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $34 Now $48 · 89% 52-wk high $50
      vs 200-day avg +7% vs 50-day avg +3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Expected sale proceeds for CommuniCare facilities $480M Q2 2026
      Facilities classified as assets held for sale 19 As of March 31, 2026
      Investments in unconsolidated entities $97M Q1 2026
      Q2 2026 new investments $75M Q2 2026
      Real estate acquisitions $126M Q1 2026
      Real estate loan fundings $27M Q1 2026
      Total new investments $251M Q1 2026
      adjusted FFO per share non-GAAP $0.82 Q1 2026 call
      AFFO dividend payout ratio non-GAAP 82% Q1 2026 call
      AFFO per share non-GAAP $0.82 Q1 2026 call
      FAD dividend payout ratio non-GAAP 86% Q1 2026 call
      FAD per share non-GAAP $0.78 Q1 2026 call
      FAD per share year-over-year growth non-GAAP 9.5% Q1 2026 call
      fixed charge coverage ratio 6.3 Q1 2026 call
      leverage ratio 3.5 Q1 2026 call
      trailing twelve-month operator EBITDAR coverage 1.58 as of 12/31/2025 call

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      OHI
      Omega Healthcare Investors Inc
      this stock
      $14.38B +10.6% +13.2% 23.2 4.7%
      WELL
      Welltower Inc.
      $163.48B +25.2% +35.6% 115.2 2.7%
      VTR
      Ventas, Inc.
      $44.08B +17.9% +18.5% 164.8 4.7%
      DOC
      Healthpeak Properties, Inc.
      $14.93B +37.1% +4.5% 67.7 3.9%
      AHR
      American Healthcare REIT, Inc.
      $10.32B +14.4% +9.1% 90.8 10.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      752
      % held
      70.2%
      Reported
      41 of 745
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      457
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      14.1M
      Days to cover
      5.8d
      Change
      +262.8K sh
      View
      Short Volume
      Short vol %
      47%
      As of
      Jul 10, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      100
      Value
      $4.5K
      As of
      Jun 2, 2026
      View
      Off-Exchange
      Off-exchange %
      39.0%
      Week of
      Jun 15, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Daniel Goldman
      Amount
      $1.0K–$15.0K
      Traded
      Mar 7, 2023
      View
      Financials
      Financials
      Revenue (FY)
      $1.2B
      Net income (FY)
      $590.2M
      EPS diluted
      $1.94
      View
      Buybacks
      Authorized
      $500.0M
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 5, 2026
      This year
      8
      View
      Proposed Sales
      Value
      $100.9K
      Shares
      2.5K
      Filed
      Aug 8, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jun 5, 2026
      View
      Investor Relations
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      OHI -2.2% +5.3% +10.2% +1.3% +10.6%
      SPY +1.4% +4.1% +9.1% +1.1% +10.7%
      vs SPY -3.6% +1.3% +1.2% +0.2% -0.1%

      Capital returns

      Latest dividend
      $0.67 / share · ex May 4, 2026
      Paid (TTM)
      $2.68 / share · 4 payouts
      Dividend yield (TTM, derived)
      5.55%
      Buyback program · as of Jun 30, 2025
      Authorized
      $500.00M
      Spent (derived)
      Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 888491 CUSIP 681936100 13F (30d) 79 filings 44 filers Visit website Investor relations